Vertex’s Sickle Cell Treatment Gets December Decision Date, On Track To Be First CRISPR Therapy

Rival Therapy Could Also Get Green Light By Year End

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.